What You Should Know:
– Gameto, a clinical-stage biotechnology company focused on reproductive health secures $44M in Series C funding, bringing its total capital raised to a leading $127M.
– The funding, led by Overwater Ventures…
Continue Reading
Promise and Paradox in Cell Therapy Growth
Cell and gene therapies (CGTs) stand at the precipice of transformative growth, with Cardinal Health’s “2025 Advanced Therapies Report” projecting over 200 FDA-approved treatments and 100,000+ U.S. patients…
Groundbreaking ISS Research Reveals Cellular Adaptations
Researchers from Emory University have made a significant discovery about heart muscle cells in space environments. Their study, published in the journal Biomaterials, demonstrates that spaceflight increases the expression…
Researchers from Emory University studying how heart muscle cells grow and function in a space environment found that spaceflight increases the expression of genes involved in stress response and cell survival, according to a…
Continue Reading
In the rapidly evolving landscape of healthcare, personalized medicine is making waves by offering tailored therapies that cater to the unique needs of individual patients. One of the most promising advancements in this field…
Continue Reading
What You Should Know: – Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including…
Continue Reading
What You Should Know:
– OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing…
Continue Reading
A team at Columbia University School of Engineering and Applied Science has developed a technique to enhance chimeric antigen receptor (CAR) T cell therapy in solid tumors. The technique involves engineering E. coli bacteria,…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
What You Should Know: Today, Rev1 Ventures, the venture studio that helps entrepreneurs and corporations accelerate innovation, Nationwide Children’s Hospital, and The Ohio State University announce expanded support for life sciences companies with the launch of Rev1 Catalyst…
Continue Reading
